| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.37B | 9.04B | 7.63B | 7.39B | 4.75B | 3.96B |
| Gross Profit | 6.01B | 7.44B | 5.99B | 5.88B | 4.31B | 3.70B |
| EBITDA | 2.73B | 2.96B | 2.42B | 2.04B | 1.65B | 1.04B |
| Net Income | 1.58B | 1.82B | 1.40B | 1.52B | 1.45B | 525.12M |
Balance Sheet | ||||||
| Total Assets | 144.53B | 204.65B | 140.59B | 142.13B | 152.30B | 136.35B |
| Cash, Cash Equivalents and Short-Term Investments | 8.60B | 12.70B | 8.99B | 10.09B | 14.00B | 21.77B |
| Total Debt | 20.63B | 26.33B | 19.87B | 25.18B | 10.02B | 7.33B |
| Total Liabilities | 132.89B | 187.05B | 129.03B | 132.56B | 144.18B | 129.49B |
| Stockholders Equity | 11.43B | 16.57B | 11.35B | 9.37B | 7.94B | 6.70B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.93B | -2.63B | -3.58B | 12.46B | 1.02B |
| Operating Cash Flow | 0.00 | 9.02B | -2.50B | -3.42B | 12.79B | 1.26B |
| Investing Cash Flow | 0.00 | 2.71B | -215.29M | -314.08M | -17.07M | -743.13M |
| Financing Cash Flow | 0.00 | -7.93B | 513.33M | -178.37M | -85.50M | -64.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | €101.07B | 13.35 | 14.41% | 6.08% | -8.94% | 11.50% | |
74 Outperform | €26.07B | 16.76 | 13.48% | 6.09% | 12.48% | 14.40% | |
73 Outperform | €5.33B | 8.88 | 13.87% | 6.23% | -10.60% | -22.83% | |
68 Neutral | €28.35B | 2.42 | 19.13% | 9.69% | 10.29% | -0.75% | |
66 Neutral | €19.45B | 5.75 | 18.92% | 8.25% | -10.25% | 8.52% | |
65 Neutral | €106.31B | 7.03 | 16.32% | 4.15% | 1.30% | 18.00% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |